Alfonso Colombatti

Alfonso Colombatti

Auto-generated profile, based on publicly available information

Alfonso Colombatti

Divisione di Oncologia Sperimentale, Centro di Riferimento Oncologico CRO-IRCCS, 33081 Aviano, Italy

Research Focus & Metrics

Academic Career Length

54Years (1973-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2012 in Oncogene
Verified
Journal Article
Open access
PDF file
Riccardo SpizzoRiccardo Spizzo
Riccardo Spizzo
Maria Ines AlmeidaMaria Ines Almeida
Maria Ines Almeida
ACA Colombatti
A Colombatti
George CalinGeorge Calin
George Calin
Tiling array and novel sequencing technologies have made available the transcription profile of the entire human genome. However, the extent of transcription and the function of genetic elements that occur outside of protein-coding genes, particularly those involved in disease, are still a matter of debate. In this review, we focus on long non-coding RNAs (lncRNAs) that are involved in cancer. We define lncRNAs and present a cancer-oriented list of lncRNAs, list some tools (for example, public databases) that classify lncRNAs or that scan genome spans of interest to find whether known lncRNAs reside there, and describe some of the functions of lncRNAs and the possible genetic mechanisms that underlie lncRNA expression changes in cancer, as well as current and potential future applications of lncRNA research in the treatment of cancer.

1 January 2014 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
Donatella AldinucciDonatella Aldinucci
Donatella Aldinucci
ACAlfonso Colombatti
Alfonso Colombatti
Until recently, inflammatory chemokines were viewed mainly as indispensable “gate keepers” of immunity and inflammation. However, updated research indicates that cancer cells subvert the normal chemokine system and these molecules and their receptors become important constituents of the tumor microenvironment with very different ways to exert tumor-promoting roles. The CCR5 and the CCL5 ligand have been detected in some hematological malignancies, lymphomas, and a great number of solid tumors, but extensive studies on the role of the CCL5/CCR axis were performed only in a limited number of cancers. This review summarizes updated information on the role of CCL5 and its receptor CCR5 in cancer cell proliferation, metastasis, and the formation of an immunosuppressive microenvironment and highlights the development of newer therapeutic strategies aimed to inhibit the binding of CCL5 to CCR5, to inhibit CCL5 secretion, or to inhibit the interactions among tumor cells and the microenvironment leading to CCL5 secretion.

1 January 2005 in Cancer Cell
Verified
Journal Article
Closed access
Gustavo BaldassarreGustavo Baldassarre
Gustavo Baldassarre
BBBarbara Belletti
Barbara Belletti
MNMilena Sabrina Nicoloso
Milena Sabrina Nicoloso
MSMonica Schiappacassi
Monica Schiappacassi
AVAndrea Vecchione
Andrea Vecchione
ACAlfonso Colombatti
Alfonso Colombatti

4 February 2014 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
ABAlois Bonifacio
Alois Bonifacio
SMSilvia Dalla Marta
Silvia Dalla Marta
Riccardo SpizzoRiccardo Spizzo
Riccardo Spizzo
SCSilvia Cervo
Silvia Cervo
ASAgostino Steffan
Agostino Steffan
VSValter Sergo
Valter Sergo

1 March 2008 in Clinical Cancer Research
Verified
Journal Article
Closed access
BBBarbara Belletti
Barbara Belletti
JVJayant S. Vaidya
Jayant S. Vaidya
SDSara D'Andrea
Sara D'Andrea
FEFrank Entschladen
Frank Entschladen
MRMario Roncadin
Mario Roncadin
SMSamuele Massarut
Samuele Massarut
Purpose: After apparently successful excision of breast cancer, risk of local recurrence remains high mainly in the area surrounding the original tumor, indicating that wound healing processes may be implicated. The proportional reduction of this risk by radiotherapy does not depend on the extent of surgery, suggesting that radiotherapy, in addition to killing tumor cells, may influence the tumor microenvironment. Experimental Design: We studied how normal and mammary carcinoma cell growth and motility are affected by surgical wound fluids (WF), collected over 24 h following breast-conserving surgery in 45 patients, 20 of whom had received additional TARGeted Intraoperative radioTherapy (TARGIT), immediately after the surgical excision. The proteomic profile of the WF and their effects on the activation of intracellular signal transduction pathways of breast cancer cells were also analyzed. Results: WF stimulated proliferation, migration, and invasion of breast cancer cell lines. The stimulatory effect was almost completely abrogated when fluids from TARGIT-treated patients were used. These fluids displayed altered expression of several cytokines and failed to properly stimulate the activation of some intracellular signal transduction pathways, when compared with fluids harvested from untreated patients. Conclusions: Delivery of TARGIT to the tumor bed alters the molecular composition and biological activity of surgical WF. This novel antitumoral effect could, at least partially, explain the very low recurrence rates found in a large pilot study using TARGIT. It also opens a novel avenue for identifying new molecular targets and testing novel therapeutic agents.

1 January 2004 in Molecular and Cellular Biology
Verified
Journal Article
Open access
PDF file
MZMiriam Zanetti
Miriam Zanetti
PBPaola Braghetta
Paola Braghetta
PSPatrizia Sabatelli
Patrizia Sabatelli
IMIsabella Mura
Isabella Mura
RDRoberto Doliana
Roberto Doliana
GBGiorgio M. Bressan
Giorgio M. Bressan
EMILINs constitute a family of genes of the extracellular matrix with high structural similarity. Four genes have been identified so far in human and mouse. To gain insight into the function of this gene family, EMILIN-1 has been inactivated in the mouse by gene targeting. The homozygous animals were fertile and did not show obvious abnormalities. However, histological and ultrastructural examination revealed alterations of elastic fibers in aorta and skin. Formation of elastic fibers by mutant embryonic fibroblasts in culture was also abnormal. Additional alterations were observed in cell morphology and anchorage of endothelial and smooth muscle cells to elastic lamellae. Considering that EMILIN-1 is adhesive for cells and that the protein binds to elastin and fibulin-5, EMILIN-1 may regulate elastogenesis and vascular cell maintenance by stabilizing molecular interactions between elastic fiber components and by endowing elastic fibers with specific cell adhesion properties.